Principle of Assay
Human Salusin beta ELISA Kit (A82430) employs the competitive enzyme immunoassay technique for the quantitative measurement of human Salusin beta in serum, plasma, tissue homogenates or other biological fluids. The 96-well microtiter plate has been pre-coated with Salusin beta antigen. During the incubation, Salusin beta present in the samples or standards competes with the fixed amount of immobilized Salusin beta for binding sites on the Biotinylated Anti-Salusin beta Antibody. The more Salusin beta present in a sample or standard, the less Biotinylated Anti-Salusin beta Antibody that binds to the plate. Following incubation, unbound Biotinylated Anti-Salusin beta Antibody is removed by washing, and an HRP-Avidin conjugate is added to the wells and the microtiter plate is incubated. Following incubation and washing, TMB substrate solution is then used to visualize the HRP enzymatic reaction by catalysis to produce a blue-coloured product that changes to yellow after addition of acidic stop solution. The density of yellow is inversely proportional to the amount of Salusin beta present in each sample or standard. The concentration of Salusin beta can then be calculated by reading the O.D. absorbance at 450nm in a microplate reader and referring to the standard curve.